Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel mouse model for carcinoembryonic antigen-based therapy.

Carlos H F Chan1, Clifford P Stanners

  • 1Department of Biochemistry and McGill Cancer Centre, McGill University, Montreal, Quebec, Canada H3G 1Y6.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|June 15, 2004
PubMed
Summary

Researchers developed a novel transgenic mouse model containing human carcinoembryonic antigen (CEA) family genes. This CEABAC mouse allows for more accurate preclinical testing of CEA-targeted cancer therapies and other applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with mortality in pancreatic adenocarcinoma patients achieving pathologic complete response after neoadjuvant therapy.

American journal of surgery·2026
Same author

Impact of biliary fungal contamination on outcomes after pancreaticoduodenectomy for pancreatic cancer.

Frontiers in oncology·2026
Same author

Obesity, survival, and chemotherapy outcomes in stage IV colorectal cancer: a retrospective study.

BMC cancer·2026
Same author

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.

Hepatology (Baltimore, Md.)·2026
Same author

Skeletal muscle mass associates with pancreaticoduodenectomy operative time in a sex-dependent manner.

BMC cancer·2025
Same author

The São Paulo International Consensus on Minimally Invasive Pancreatic Surgery for Cancer.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2025

Area of Science:

  • Oncology
  • Genetics
  • Immunology

Background:

  • Novel cancer therapies like immunotherapy target tumor-associated molecules such as carcinoembryonic antigen (CEA).
  • Existing animal models often fail to accurately predict clinical outcomes due to a lack of human CEA family genes in rodents.
  • This discrepancy hinders the development and efficacy testing of targeted cancer treatments.

Purpose of the Study:

  • To create a transgenic mouse model that accurately expresses human CEA family genes.
  • To enable more reliable preclinical evaluation of CEA-targeted therapies.
  • To explore new therapeutic targets and applications for CEA family genes.

Main Methods:

  • Construction of a 187-kb human bacterial artificial chromosome (CEABAC) containing key human CEA family genes (CEACAM5, CEACAM3, CEACAM6, CEACAM7).

Related Experiment Videos

  • Generation of CEABAC transgenic mice.
  • Analysis of the spatiotemporal expression patterns of the introduced human genes in the mouse model.

    • Main Results:

    • The CEABAC mice successfully express human CEA family genes.
    • The expression pattern of these genes in CEABAC mice closely mimics human expression.
    • This model provides a superior platform for preclinical assessment of CEA-targeted therapies.

    Conclusions:

    • The CEABAC mouse model offers a significant advancement for preclinical testing of cancer therapies targeting carcinoembryonic antigen (CEA).
    • This model facilitates the evaluation of CEACAM6 as a potential therapeutic target in various cancers.
    • Potential applications extend to developing treatments for infections, such as Neisseria gonorrhoeae, that utilize CEA family receptors.